scout.yahoo.com
Yahoo Scout
Yahoo Scout
天文学好可怕
Searching…
Web results
www.nytimes.com
F.D.A. FacesUpset Over Denials of NewDrugs - The New York Times
Mar 5, 2026 · But the agency has increasingly issued drugrejections or refusals — about 20 in the last eight months — that underscore a break from decades of general stability in the F.D.A.’s top...
dnyuz.com
F.D.A. FacesUpset Over Denials of NewDrugs - DNyuz
Mar 5, 2026 · Former agency officials rejected their share of newdrugs, upholding standards that caused drugmakers to abandon many therapies. But in interviews, they defended their overall record.
wavebrowsernews.com
F.D.A. FacesUpset Over Denials of NewDrugs - Wave News
Mar 5, 2026 · The FDA under the current administration has tightened the gate on new rare-disease drugs, prompting anxiety among families who depend on experimental therapies as denials mount after an initial period o...
politomix.com
F.D.A. FacesUpset Over Denials of NewDrugs - politomix.com
Mar 5, 2026 · Agency officials promise fast reviews of new treatments while vowing they will not be a “rubber stamp” for the industry. But patients with rare diseases view recent decisions as signs that the doors are ...
projectalive.org
F.D.A. FacesUpset Over Denials of NewDrugs | Project Alive
Mar 5, 2026 · A recent New York Times article highlights ongoing discussions about how the FDA evaluates and approves treatments for rare diseases, and how federal health policy decisions could impact the pace of drug...
www.cnbc.com
FDA watchers warn of agency in 'chaos' and risk to America's ...
Mar 3, 2026 · The FDA has come under criticism for the recent rejection of several newdrugs for rare diseases. Pharmaceutical firms and rare disease advocates have pointed at what they say are inconsistencies ...
arstechnica.com
FDA slows down on drug reviews, approvals amid Trump admin ...
Oct 21, 2025 · Amid the chaos of the Trump administration’s haphazard job cuts and a mass exodus of leadership, the Food and DrugAdministration is experiencing a slowdown of drug reviews and approvals,...